Insulet Corporation faces a securities class action lawsuit filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased or otherwise acquired the company’s securities between February 21, 2025, and May 26, 2026. Bragar Eagel & Squire, P.C. announced the action from New York on August 28, 2026, alleging that defendants made materially false and misleading statements about Insulet’s business, operations, and compliance policies. The suit claims the company failed to disclose that its manufacturing controls and procedures were defective, creating a foreseeable heightened risk that one or more products would violate applicable safety regulations or pose a risk of injury, and that public statements were therefore materially false and misleading throughout the class period. Insulet trades on Nasdaq under the ticker PODD. Investors who bought Insulet securities during the class period and suffered losses have until August 31, 2026, to apply to the court for appointment as lead plaintiff. The firm invited contact with partners Brandon Walker or Melissa Fortunato at investigations@bespc.com or (212) 355-4648, stating there is no cost or obligation.